In this study, tyrosinase mRNA expression has been prospectively evaluated, immediately after surgical treatment and during follow-up, in 110 stage III disease-free melanoma patients, with the aim of defining the relationship between the tyrosinase detection and the clinical course of the disease. This evidence concerns the gene TYR and melanoma.